Spineart Gains IDE Approval for BAGUERA C Trial

Spineart BAGUERA-C

Spineart received Investigational Device Exemption (IDE) approval from FDA to initiate a clinical trial of the BAGUERA® C Cervical Disc Prosthesis. The single-level trial compares BAGUERA C to another FDA approved arthroplasty device at up to 30 centers across the U.S.

BAGUERA C is an MRI compatible disc. Anatomically shaped endplates...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us